Semma Therapeutics
2014
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Series B
LATEST DEAL TYPE
$114M
LATEST DEAL AMOUNT
13
INVESTORS
Description
Developer of trans-formative therapies designed to eliminate the use of insulin injections for type 1 diabetes patients. The company's trans-formative therapies is a cell-based therapy for diabetes which traditionally requires use of an invasive insulin pump or multiple daily insulin injections combining proprietary cells with a state-of-the-art device to provide a replacement for the missing beta cells in a diabetic patient without immunosuppression.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
- 450 Kendall Street
- Suite 2B
- Cambridge, MA 02142
- United States
+1 (857) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Semma Therapeutics’s full profile, request a free trial.
Semma Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 30-Nov-2017 | $114M | 00000 | Completed | Product Development | |
| 2. Grant | 12-Sep-2016 | 000 | 0000 | Completed | Product Development | |
| 1. Early Stage VC (Series A) | 24-Mar-2015 | $44M | $44M | 000.00 | Completed | Product Development |
Semma Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Semma Therapeutics Competitors (31)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Humacyte | Venture Capital-Backed | Durham, NC | 00 | 00000 | 000000000000 | 00000 |
| 0000 000000 | Formerly VC-backed | Santa Monica, CA | 000 | 00000 | 000000&0 | 00000 |
| 0000000 | Venture Capital-Backed | San Diego, CA | 00 | 00000 | 00000000000 | 00000 |
| 000000000000 00000 | Venture Capital-Backed | Madison, WI | 00.000 | 0000000000 0 | 00.000 | |
| 0000 000000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 00000000000 | 00000 |
Semma Therapeutics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 16-Nov-2015 | 000000000000000000 | Therapeutic Devices | 0000000 000000 00.0 |
Semma Therapeutics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| 6 Dimensions Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Cowen Group | Investment Bank | Minority | 000 0000 | 000000 0 | ||
| Eight Roads | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| ORI Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Sinopharm Capital | PE/Buyout | Minority | 000 0000 | 000000 0 |
Semma Therapeutics Executive Team (12)
1 Former Executive
You’re viewing 5 of 12 executives. Get the full list »Semma Therapeutics Board Members (12)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Daniel Auerbach | Eight Roads | Board Member | 000 0000 | |
| David Neustaedter Ph.D | Medtronic | Board Observer | 000 0000 | |
| Douglas Melton Ph.D | Semma Therapeutics | Scientific Co-Founder and Board Observer | 000 0000 | |
| James Scopa JD | MPM Capital | Board Member | 000 0000 | |
| Kevin Raidy | Cowen Group | Board Member | 000 0000 |
2 Former Board Members
You’re viewing 5 of 12 board members. Get the full list »